Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer
By E. Dijkers, T. O. Oude Munnink, J. Kosterink, A. Brouwers, P. L. Jager, J. R. Jong, G. Dongen, C. Schröder, M. L. Lub-de Hooge, E. Vries. Clinical pharmacology and therapy, 2010
754 citations recorded by the source corpus.
Subfields: Oncology, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/da8774988a8bda69deab8ff65e53c79630d36b08
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- Antibody therapy of cancer (2012, methodology): “Examples of the successful use of this approach include the early biodistribution studies of mouse EGFR-specific antibodies 528 and 225 (which were preludes to cetuximab), which identified the liver antigen sink (due to the expression of wild-type EGFR) for systemic antibody and its effect on the co”